Crocs heads into its third-quarter report with an unusual setup: management has raised its full-year outlook three quarters running, yet the Street still appears reluctant to fully believe it. The October 29 report, due before the open, will be the first quarter to absorb a revenue-recognition change in North America that mechanically shrinks the top line. That makes it a test of whether the turnaround story can survive messier optics.
CSW Industrials heads into its fiscal second-quarter report with an odd mismatch between what the business said last time and how the stock has behaved since. Three months ago, management delivered record revenue, record adjusted EBITDA and a second straight quarter of positive organic growth, yet the shares have slipped about 1.5% while the S&P 500 gained roughly 4.5%. The stock briefly ran as high as $355 after that report and has since surrendered the entire move, leaving it near $290, just under its 200-day moving average and not far above the post-earnings low near $280. The market, in other words, has taken the good news and decided to wait for proof.
Three months ago, Cognizant gave investors a split verdict: it raised its full-year earnings outlook while trimming the top of its revenue range, conceding that the discretionary spending rebound it had counted on never showed up. The market has since chosen to focus on the good half of that message. Shares have climbed about 30% since the last report, beating the S&P 500 by more than 26 percentage points. That shifts the burden of proof for the third-quarter release, due before the open on October 29. The stock is now priced for a company whose demand is stabilizing, not one that just lowered its sales ambitions.
For the better part of a year, the story at California Water Service Group was about waiting. The company's 2024 California general rate case sat unresolved through three straight earnings calls, and the uncertainty hung over everything. Last quarter that changed: the decision was finalized, new rates hit customer bills on July 1, and management sounded more confident than it had in some time. Yet the stock has since dropped 13.2%, trailing the S&P 500 by nearly 18 percentage points. The third-quarter report, due before the open on October 29, is the first full period to show what the resolved rate case actually looks like in the numbers, and it arrives with the market plainly skeptical.
Darling Ingredients delivered the kind of quarter last time that rewrites a company's story: renewable diesel profits exploded, leverage fell sharply and management sounded confident enough to start buying back stock. Yet the shares have gone nowhere since. When the company reports before the opening bell on October 29, the question is whether the third quarter shows that the second-quarter surge was a new baseline or a peak padded by items that will not repeat.
Donnelley Financial Solutions heads into its third-quarter report with a curious disconnect. Management came out of the last call sounding as confident as it has in some time, pointing to record margins, a fourth straight quarter of 20%-plus growth in Active Disclosure and a capital markets deal recovery strong enough to lift near-term guidance. Yet the mood around the stock has cooled noticeably, and the shares are sitting just below their post-earnings high. That combination makes this report less about whether DFIN can grow and more about whether the deal rebound and software momentum can carry through a seasonally quieter quarter.
Donegal Group's last quarter looked better on the income statement than it did underneath. Second-quarter net income rose about 32% and the combined ratio improved to 95.6%, but most of that came from unusually mild weather and larger releases of prior-year reserves. Premiums kept shrinking, pricing kept cooling and the expense ratio kept climbing. The third-quarter report, due before the open on October 29, will show how much of the franchise's earnings power remains once those two tailwinds stop doing the heavy lifting.
D.R. Horton enters its fiscal fourth-quarter report with a split personality. Its margins have been beating expectations, but its sales volume keeps disappointing. Last quarter the builder posted a home sales gross margin above the top of its own guidance, yet it cut its full-year revenue and closings outlook for the second straight time. The October 29 report, due before the open, will show which of those two trends deserves more weight heading into fiscal 2027.
Leonardo DRS heads into its third-quarter report with an awkward mismatch. On the operating side, management has raised its full-year profit outlook twice, organic growth reaccelerated last quarter and orders keep outrunning sales. In the market, the stock has fallen 27.3% since that upbeat report while the S&P 500 gained 4.5%. When the company reports before the open on October 29, the results need to show whether the business story or the share price has the better read on what comes next.
DT Midstream heads into its third-quarter report with an unusual setup: management has already told investors the quarter will be softer, and the stock has been punished anyway. Since the last report, shares have fallen 8.1% while the S&P 500 gained 4.5%, a 12.6-point gap that has opened even as the company's long-term growth pipeline kept expanding. That disconnect makes this report less about the quarter itself and more about whether the near-term wobble is as temporary as management insists.
Enerflex enters its third-quarter report with a story that sounds better than its recent income statements look. Management spent the last call pointing to record bookings, a record $1.5 billion backlog and a distributed power pipeline that has grown more than sevenfold in under a year. Meanwhile revenue, adjusted EBIT and earnings per share all slipped. The report due before the open on October 29 is the first real chance to see whether that order book is starting to show up in revenue, or whether the gap between orders and results is getting wider.
EMCOR heads into its third-quarter report with an odd mismatch. The operating story has rarely looked better, with two consecutive guidance raises, record remaining performance obligations and a five-deal electrical acquisition spree. Yet the stock has fallen 9% since the last report while the S&P 500 gained 4.5%, and it now trades just above its post-earnings low. The October 29 release, due before the open, is a test of whether the fundamentals can win that argument.
Three months ago Entegris abandoned the cautious, wait-and-see tone of the past year and told a confident upcycle story. Revenue growth was accelerating, gross margin hit its highest level since early 2022, debt was falling faster than planned, and the capital-spending business had flipped from decline to double-digit growth. The third-quarter report, due before the open on October 29, is the first chance to show that story holds up in the numbers. The catch is that analysts have already priced in a strong result.
Enterprise Products Partners heads into its third-quarter report with a question that its record second quarter could not answer: how much of that strength was the durable, fee-based machine, and how much was a one-time gift from a disrupted Strait of Hormuz? Management said roughly $200 million of spread capture tied to the Iran conflict had largely normalized by the time it spoke in the summer. That makes the coming release, due before the open on October 29, the first clean look at the partnership's earnings power without that tailwind.
Establishment Labs heads into its third-quarter report with an odd disconnect. Management has raised its full-year revenue outlook three times in a row, US sales more than doubled last quarter, and the company finally produced positive overall cash flow. Yet the stock has lost nearly a third of its value since that report. The October 29 release, due before the open, has to show whether the American growth engine can carry the business through what management itself flagged as the seasonally softest quarter of the year, while a slowing international business drags on the totals.
FTI Consulting heads into its third-quarter report with a split personality. The top line has been doing its job, and the economic consulting business that dragged on results for more than a year finally turned higher last quarter. Yet profits have not kept pace. Margins compressed, overhead kept climbing, and management trimmed its full-year GAAP earnings outlook for the first time after two straight reaffirmations. The October 29 release, due before the market opens, is the first real chance to see whether the revenue story can start translating into earnings again.
Forbright heads into its third-quarter report with an unusual math problem hanging over the stock. Analysts expect the bank holding company to earn $0.32 per share on revenue of about $89.4 million, which would more than triple the $0.09 it earned last quarter even as the top line shrinks sharply from the $150.9 million reported then. A smaller revenue base paired with a much larger profit is not the typical shape of a healthy bank quarter. So the release must show whether the Street is right that earnings power is improving underneath the noise, or whether the latest quarter's weak bottom line was closer to the real run rate.
Federal Signal has spent 2026 doing almost everything a bull could ask for. It has raised full-year earnings guidance twice, expanded margins, generated cash at a striking clip and integrated its New Way and Mega acquisitions faster than planned. Yet the stock has slipped about 5% since its last report while the S&P 500 gained 4.5%. That gap suggests the market is less focused on the record quarter behind it than on the softer signals underneath: a shrinking backlog, slipping Safety and Security Systems orders and a refuse market management itself expects to decline. The third-quarter report on October 29 is the first real chance to show those soft spots are noise rather than a turn.
FTAI Aviation heads into its third-quarter report with a stock that has been treated as if the bad news outweighed the good. Last quarter brought a signed $1.465 billion power order and a higher module production target, but also a roughly $100 million cut to Aviation Leasing EBITDA guidance and an acknowledgment that Aerospace Products margins are settling near 30%, well short of the 40% ambition management had cited for several quarters. Since then the shares have fallen 14.6% while the S&P 500 gained 4.5%. This report needs to show which half of that story deserves more weight.
TechnipFMC heads into its third-quarter report with an unusual disconnect. Last quarter, management raised full-year EBITDA guidance, pushed its free cash flow outlook to the top of the range and delivered its best subsea margin since the demerger. Yet the stock has slipped 3.6% since then while the S&P 500 gained 4.5%. The October 29 release, due before the open, is the first real test of whether the second-quarter step-up was a new baseline or a high-water mark.
Fortrea enters its third-quarter report with an unusual setup: management raised its full-year outlook three months ago, yet Wall Street still has not fully bought in. The contract research organization lifted its 2026 revenue forecast to $2.62 billion to $2.69 billion, up from $2.55 billion to $2.65 billion, while the consensus sits at roughly $2.61 billion, below even the bottom of the new range. That gap between what the company says and what analysts are willing to model is the central tension heading into the October 29 release before the opening bell.
Fiverr enters its third-quarter report with the hard part already announced. Three months ago management cut its full-year outlook, guided to a revenue drop of as much as 26%, and blamed a fresh slowdown in marketplace traffic on large language models and Gemini's arrival inside Google Search. The question for this report is not whether the quarter will be weak, since that is spoken for. It is whether the damage stopped where management said it would, or whether the AI-driven erosion of the top of the funnel is still outrunning the company's push upmarket.
GATX heads into its third-quarter report with an awkward disconnect. Three months ago management raised full-year guidance, said its record Wells Fargo rail acquisition was running well ahead of plan, and struck its most confident tone in a year. Since then the stock has fallen 15.3% while the S&P 500 gained 4.5%, a gap of nearly 20 percentage points. Either the market is skeptical that the upgraded story holds, or it is pricing in risks management has played down. The October 29 release, due before the open, is the first real chance to settle that argument.
Garrett Motion heads into its third-quarter report with an odd disconnect. Management has raised its full-year outlook three calls in a row, posted a record adjusted EBIT margin of 15.6% last quarter and introduced a string of new markets well beyond the turbocharger business it is known for. Yet the stock has fallen 17.2% since that report, trailing the S&P 500 by about 21 percentage points. The October 29 release, due before the open, needs to show that the operating story has not quietly cracked.
Granite Construction heads into its third-quarter report with an odd disconnect. Management has raised its 2026 revenue outlook at every opportunity, lifted its 2027 organic growth target above 10%, and built a record pipeline of contracted work. The stock, by contrast, has slipped 4.3% since the last report while the S&P 500 gained 4.5%. The peak construction season now has to show whether the operating story deserves more credit than the market has been willing to give.
Hyatt has spent 2026 raising the bar on itself. Its systemwide RevPAR outlook has climbed at every stop this year, from 1% to 3% at the start, to 2% to 4%, and most recently to 3.5% to 4.5%. The U.S. range followed the same path. That kind of momentum earns credibility, but it also tightens the leash. When Hyatt reports third-quarter results before the open on October 29, the question is less whether demand is healthy and more whether the company can keep that streak going while its rooms growth story leans heavily on a crowded fourth quarter.
Three months ago, Hilton Grand Vacations told investors that demand was fine but its salespeople were not. The timeshare operator kept its full-year profit target intact while cutting its contract sales and volume per guest outlook, and it pinned part of the shortfall on weak execution at two of its busiest Bluegreen sites, Orlando and Myrtle Beach. The third-quarter report on October 29, before the opening bell, is the first real chance to see whether that diagnosis was right and whether the new leadership installed at those locations is stopping the slide.
Huntington Ingalls heads into its third-quarter report with an odd mismatch. Three months ago management delivered the most confident update in years, finally signing the long-delayed Virginia-class Block 6 and Columbia submarine contract modifications, raising full-year shipbuilding revenue guidance by roughly $500 million and lifting the floor of its margin range. Yet the stock has since fallen about 11%, trailing the S&P 500 by nearly 16 percentage points. The report before the open on October 29 needs to show whether the operational turn is real enough to close that gap.
Hippo walks into its third-quarter report carrying the weight of its own optimism. Three months ago, management raised full-year guidance on every line it tracks, cut its combined ratio target by four points, pulled its $2 billion premium milestone forward to 2027 and lifted its 2028 profit goal. That was the most confident call in recent memory. This report is the first chance to see whether that confidence was earned or front-loaded.
Three months ago Harley-Davidson finally gave investors what the turnaround story had lacked: a guidance raise across nearly every line. The third-quarter report now has to show that the improvement was more than a well-timed spring. That will be harder to prove, because the quarter loses a one-time tariff recovery that flattered the second quarter. It also brings Europe's slide into sharper focus and arrives against a Street forecast that already assumes a steep contraction.
Hershey heads into its third-quarter report with a story that has improved on paper but deteriorated in the stock market. Last quarter, management nudged up full-year guidance, argued that real chocolate demand was running well ahead of what scanner data showed, and said it now has good visibility into cocoa deflation next year even if futures stay where they are. Since then the shares have fallen 7% while the S&P 500 gained 4.5%, a gap of more than 11 percentage points. The Halloween quarter now has to show whether the market was right to look past the upbeat commentary or whether it has priced in too much worry.
Howmet Aerospace heads into its third-quarter report with an odd mismatch between the business and the stock. Management has raised its full-year outlook on every call for a year, organic growth accelerated to 21% last quarter, and margins keep climbing. Yet the shares have fallen about 29% since the last report while the S&P 500 barely moved. That gap makes this report less about whether Howmet beats a number and more about whether it can convince a doubtful market that the growth runway extends comfortably into 2027.
Intercontinental Exchange spent its last earnings call making a bigger argument than a single strong quarter. Management lifted recurring revenue targets in two segments, raised the buyback baseline and agreed to buy MarketAxess for roughly $5.7 billion, framing the business as one whose growth is broadening rather than leaning on market turmoil. The third-quarter report, due before the open on October 29, is the first real test of whether that more confident story holds once the extraordinary volatility of early 2026 fades from the comparisons.
IDACORP heads into its seasonally most important quarter with a story that has finally moved from promise to proof. Last quarter management argued that years of planning for large industrial customers had begun turning into real revenue, and it backed that claim by lifting the bottom of its full-year earnings range. The stock has not followed the narrative. Shares have fallen 5.7% since that report while the S&P 500 gained 4.5%, leaving IDACORP about 10 points behind the market just as the summer quarter puts the large-load thesis to its biggest test yet.
InterDigital's last report was the kind that resets a story. Revenue of $260.2 million nearly doubled the company's own forecast, the long-promised streaming and cloud licensing program finally produced real money, and management lifted its full-year outlook by $85 million at the midpoint. The upcoming third-quarter report will look tamer by design. The real question is whether the forces behind that breakout, Amazon's agreement to license and mounting legal pressure on Disney, keep building beneath a quieter headline.
Incyte heads into its third-quarter report carrying the strongest operating narrative it has had in years and a headline loss that will look alarming at first glance. Consensus calls for a GAAP loss of $3.87 a share, a swing that largely reflects the roughly $1.27 billion upfront charge for the July acquisition of Vega Therapeutics and its Phase 3 von Willebrand disease drug, latarcibart. That number is mostly accounting noise. The real question is whether the commercial engine that justified two consecutive guidance raises is still running hot once last quarter's one-time help is stripped away.
Indivior enters its third-quarter report with an unusual gap between what management says and what Wall Street models. The company's latest outlook calls for 2026 revenue of $1.295 billion to $1.365 billion, up from a prior range of $1.215 billion to $1.285 billion. The full-year consensus of roughly $1.26 billion, however, sits below even the low end of that raised range. The stock has also slid since the last report. That combination makes this print less about clearing a bar and more about proving that the bar is set too low.
Three months ago Insmed delivered the most confident quarter in its recent history, raising Brinsupri guidance, nearly doubling portfolio peak-sales targets and declaring that demand for its new bronchiectasis drug was now fully organic. The market's response since then has been brutal. Shares have fallen about 25% while the S&P 500 has been roughly flat, leaving the stock near $96, just above its post-earnings low of $94.38 and far below its 200-day moving average around $128.50. That disconnect frames the third-quarter report, due before the open on October 29: either the operating story is intact and the selloff overshot, or investors are sensing a ramp that is harder to sustain than management suggested.
KBR heads into its third-quarter report with a story that sounds better than its recent numbers look. Management left the last call more confident than at any point in the past year, pointing to a record Sustainable Technology Solutions backlog, expanding margins and a defense spin-off that is moving on schedule. Yet consolidated revenue grew only 2% last quarter, cash conversion slipped, and full-year guidance was reaffirmed rather than raised. This report is the first real chance to see whether that accumulated backlog is turning into reported growth and collected cash.
Kimco Realty heads into its third-quarter report with an unusual disconnect. Over the past several calls, management has raised its full-year funds from operations floor, posted record occupancy and delivered a 12% dividend increase. Yet the stock has fallen 9.5% since the last report while the S&P 500 edged up 1.1%. The October 29 release, due before the open, will show whether that selloff reflects a real crack in the fundamentals or simply impatience with a story whose upside has been capped by its own guidance.
Laureate Education spent the first half of 2026 shifting from cautious reaffirmations to an outright raise of its full-year outlook, and the third-quarter report is where that new confidence has to show up in hard numbers. The quarter captures the September primary intake in Mexico, the most important enrollment event of the year, which management described last quarter as roughly half complete and tracking to plan. Whether that intake landed as cleanly as promised will largely decide whether the raised guidance looks conservative or merely adequate.
Ligand Pharmaceuticals heads into its third-quarter report with an unusual mismatch between what management has promised and what analysts have penciled in. After closing the Zoma royalty acquisition and calling the current stretch its most catalyst-rich period in roughly four decades, the company tightened its 2026 adjusted earnings outlook to $9.00 to $9.50 per share, lifting the floor from $8.50. Yet the full-year consensus sits at $8.79, below the new low end. Either the Street is being stubbornly cautious, or estimates simply have not caught up. The October 29 release, due before the open, should settle which.
L3Harris heads into its third-quarter report with an awkward mismatch between what management is saying and what the stock is doing. Three months ago the company raised its full-year outlook for the second straight quarter, posted record backlog and described its most confident demand picture in a year. Since then the shares have fallen 10.5% while the S&P 500 gained 4.5%, a 15-point gap that suggests the market either doubts the momentum or is pricing in risks the guidance does not capture. This report is the first real chance to show which view is right.
Linde heads into its third-quarter report with two stories that do not quite agree. Demand looks healthier than it has in some time, with a record backlog, a fresh $1 billion electronics win and volumes finally recovering in the Americas and Asia. Yet the company that built its reputation on steady margin expansion just posted its first year-over-year margin decline, and management responded by putting its US home care business, Lincare, under strategic review. The October 29 release, due before the open, is the first chance to see whether that margin dip was a blip or a trend.
Three months ago LKQ's story flipped from green shoots in North America to damage control in Europe, and the third-quarter report is the first real chance to learn which of those narratives carries more weight. A botched ERP conversion in Germany, which management had described only a quarter earlier as running ahead of plan, wiped out roughly $140 million of revenue and $50 million of EBITDA in the second quarter and forced the company's first guidance cut in this cycle. The question now is whether that disruption was a one-quarter stumble or the start of a longer slog.
Eli Lilly heads into its third-quarter report with a peculiar expectations gap. The published consensus calls for a quarter that looks softer than the last one on paper, yet the stock is near its highs and the unofficial bar sits far above the official one. Management told investors in July that the second half would slow in dollar terms, and the question now is whether the catalysts it described as inflection points arrived quickly enough to make that warning look conservative.
Cheniere Energy has turned guidance raises into something of a habit this year, and that is exactly what makes its third-quarter report on October 29 interesting. Full-year 2026 adjusted EBITDA guidance has climbed from roughly $6.6 billion to $7.0 billion when first introduced to $7.9 billion to $8.4 billion today. The latest increase came with a low end that sits above the prior high end. With a disrupted global LNG market still handing the company unusually rich spot margins, the question is not whether Cheniere is executing. It is whether there is room left for a third consecutive lift, and how much of that the market already assumes.
Three months ago, Life Time delivered the kind of quarter growth investors usually reward: comparable center revenue re-accelerated, margins widened, and management raised nearly every line of its full-year outlook while declaring itself more excited than ever. The market shrugged. Shares have fallen 9.2% since that report while the S&P 500 gained 4.5%, and sentiment has turned noticeably more bearish. That gap between operating momentum and stock performance is what makes the third-quarter report, due before the open on October 29, worth close attention.
Three months ago, Mastercard turned what management had framed as a trough quarter into a quiet upside surprise. Cross-border travel improved faster than feared as Middle East disruption eased, U.S. volumes outside the Capital One migration sped up, and the company said full-year revenue should land higher within its range. When Mastercard reports third-quarter results before the open on October 29, the question is whether that recovery carried through the second half. The stock now trades just below its post-earnings high, so investors have already priced in much of the improvement.
Mobileye heads into its third-quarter report with an awkward split between what management has been saying and what the market has been doing. The company has raised its full-year revenue outlook on three straight calls, yet the stock has slid about 10% since the last report while the S&P 500 gained 4%. That gap frames the October 29 release, due before the open: investors seem to doubt that the improving core story can outlast a weaker second half, a costly Robotaxi push and a leadership change.